Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.
Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Int J Colorectal Dis. 2021 Jun;36(6):1287-1295. doi: 10.1007/s00384-021-03871-4. Epub 2021 Feb 11.
This study evaluated the results of laparoscopic surgery (LAP) compared to open surgery (OP) for locally advanced mid-to-lower rectal cancer.
From February 2008 to December 2014, we collected patient data with clinical stage II/III mid-to-lower rectal cancer who underwent resection with LAP or OP at 13 institutions associated with the Yokohama Clinical Oncology Group (YCOG). The short-term outcomes and long-term prognoses associated with LAP and OP were analyzed after adjusting for the patients' backgrounds using propensity score matching.
Among 1091 eligible cases, a propensity score matching with six covariates-age, sex, body mass index, American Society of Anesthesiologists physical status category, tumor location, and clinical stage-extracted 237 cases each for the LAP and OP groups, respectively. After matching, there were no differences in background factors between the two groups except for the presence or absence of preoperative treatment. Operative time was significantly longer in the LAP group than that in the OP group (p < 0.001), while the amount of bleeding and the length of postoperative hospital stay were significantly lower in the LAP group than that in the OP group (p < 0.001 and p = 0.001, respectively). There were no significant differences between groups in the incidence of postoperative complications. The 3-year overall survival and relapse-free survival rates were 90.5% and 88.6% and 78.3% and 71.6% in the LAP and OP groups, respectively, which did not differ significantly.
The short-term outcomes and long-term prognoses of LAP in this cohort study indicated that LAP could be a therapeutic option for locally advanced rectal cancer.
UMIN000040406.
本研究评估了腹腔镜手术(LAP)与开腹手术(OP)治疗局部进展期中下段直肠癌的效果。
从 2008 年 2 月至 2014 年 12 月,我们收集了在与横浜临床肿瘤学会(YCOG)相关的 13 家机构接受 LAP 或 OP 切除术的临床分期为 II/III 期中下段直肠癌患者的临床数据。通过倾向评分匹配,调整患者背景后,分析 LAP 和 OP 相关的短期结果和长期预后。
在 1091 例合格病例中,通过倾向评分匹配 6 个协变量(年龄、性别、体重指数、美国麻醉医师协会身体状况分类、肿瘤位置和临床分期),分别为 LAP 和 OP 组各提取 237 例。匹配后,两组间除术前治疗的有无外,背景因素无差异。LAP 组的手术时间明显长于 OP 组(p<0.001),而 LAP 组的出血量和术后住院时间明显短于 OP 组(p<0.001 和 p=0.001)。两组术后并发症发生率无差异。LAP 和 OP 组的 3 年总生存率和无复发生存率分别为 90.5%和 88.6%、78.3%和 71.6%,差异无统计学意义。
本队列研究中 LAP 的短期结果和长期预后表明,LAP 可能是局部进展期直肠癌的一种治疗选择。
UMIN000040406。